From the Clinical to the Bench: Exploring the Insulin Modulation Effects of Tacrolimus and Belatacept
Calcineurin inhibitors (CNIs) are critical in preventing rejection posttransplantation but pose an increased risk of post-transplant diabetes (PTD). Recent studies show that late conversion from CNIs to belatacept, a costimulation blocker, improves HbA1c in kidney transplant recipients with PTD or d...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-04-01
|
| Series: | Cell Transplantation |
| Online Access: | https://doi.org/10.1177/09636897241246577 |